dcsimg
September 26, 2018
Hot Topics:

Did Tech Oversell AI?

  • August 14, 2018
  • By Developer.com Staff

The Wall Street Journal has a lengthy article detailing a problem for the IBM Watson artificial intelligence (AI) platform. The company offers several services aimed at better treating cancer, but so far no clinical trials have shown that Watson improved outcomes.

In related news, researchers from Google's DeepMind subsidiary have published a paper in Nature Medicine which claims that its AI is about as accurate as a human physician at diagnosing eye diseases. In tests, the system made the same diagnosis as a panel of eight doctors more than 94 percent of the time. An ophthalmologist involved with the study said, “The number of eye scans we’re performing is growing at a pace much faster than human experts are able to interpret them. There is a risk that this may cause delays in the diagnosis and treatment of sight-threatening diseases. If we can diagnose and treat eye conditions early, it gives us the best chance of saving people’s sight. With further research it could lead to greater consistency and quality of care for patients with eye problems in the future.”

View article






Comment and Contribute

 


(Maximum characters: 1200). You have characters left.

 

 


Enterprise Development Update

Don't miss an article. Subscribe to our newsletter below.

By submitting your information, you agree that developer.com may send you developer offers via email, phone and text message, as well as email offers about other products and services that developer believes may be of interest to you. developer will process your information in accordance with the Quinstreet Privacy Policy.

Sitemap

Thanks for your registration, follow us on our social networks to keep up-to-date